Replies to post #680 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Thanks, Aslan. Nothing really new in this article, but it’s a reasonable synopsis of the transgenics industries (plural).

The author did make one major omission, however: they neglected to mention that Merck recently paid $400M in cash to acquire Glyco Fi.

Moreover, Pharming, n.v., despite all of its cited troubles, has a market cap about three times as high as GTCB’s!